Palliative care on the radiation oncology ward—improvements in clinical care through interdisciplinary ward rounds Michael OertelRenate SchmidtPhilipp Lenz Original Article Open access 11 August 2022 Pages: 251 - 257
The tumor core boost study: A feasibility study of radical dose escalation to the central part of large tumors with an integrated boost in the palliative treatment setting Olaf WittensteinFabian KrauseJuergen Dunst Original Article Open access 20 July 2022 Pages: 258 - 267
Physical and nonphysical effects of weekly music therapy intervention on the condition of radiooncology patients Patrick ClemensPhilipp SzeverinskiAlexander de Vries Original Article 24 December 2022 Pages: 268 - 277
Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation Carsten NiederEllinor C. HauklandAstrid Dalhaug Original Article Open access 10 January 2023 Pages: 278 - 283
Traditional risk factors and nodal yield—still relevant with high-quality risk-adapted adjuvant treatment for locally advanced head and neck cancer? Y. ButtP. TennstedtS. Tribius Original Article 09 November 2022 Pages: 284 - 292
Surgical resection versus transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma Benoît AllignetPierre PradatPhilippe Merle Original Article 28 November 2022 Pages: 293 - 303
Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer Hisashi YamaguchiTakahiro KatoShinichi Konno Original Article 29 November 2022 Pages: 304 - 312
Chemoradiotherapy for untreated Masaoka–Koga stage IVB thymic carcinoma: a single-center retrospective study Jia-nan JinYue HaoZheng-bo Song Original Article 02 February 2023 Pages: 313 - 321
Testicular germ cell tumour arising 15 years after radiotherapy with 18 Gy for germ cell neoplasia in situ Klaus-Peter DieckmannSilke TribiusChristian Wülfing Case Study 28 November 2022 Pages: 322 - 326
Verlängerung des Gesamtüberlebens durch die Impfung von autologen tumorlysatbeladenen dendritischen Zellen (DCVax-L) bei Patienten mit neu diagnostiziertem und rezidivierendem Glioblastom Maximilian Y. DengJürgen DebusLaila König Literatur kommentiert Open access 20 January 2023 Pages: 327 - 329
SBRT von primären Nierenzellkarzinomen – Langzeitergebnisse der IROCK-Datenbank Alexander RühleSimon Kirste Literatur kommentiert Open access 06 February 2023 Pages: 330 - 332
Kardiovaskuläre Risikoevaluation in der Behandlung des Hodgkin-Lymphoms – auf dem Weg zur individualisierten Planung? Michael OertelHans Theodor Eich Literatur kommentiert Open access 07 February 2023 Pages: 333 - 336